Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

MLA

Ok, Chi Young, et al. “Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de Novo Diffuse Large B-Cell Lymphoma in Western Countries.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 20, no. 9, May 2014, pp. 2338–49. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-13-3157.

APA

Ok, C. Y., Li, L., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Manyam, G. C., Montes-Moreno, S., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Chen, J., Richards, K. L., Hsi, E. D., Choi, W. W. L., van Krieken, J. H., Huh, J., Ai, W., … Young, K. H. (2014). Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 20(9), 2338–2349. https://doi.org/10.1158/1078-0432.CCR-13-3157

Chicago

Ok, Chi Young, Ling Li, Zijun Y Xu-Monette, Carlo Visco, Alexander Tzankov, Ganiraju C Manyam, Santiago Montes-Moreno, et al. 2014. “Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de Novo Diffuse Large B-Cell Lymphoma in Western Countries.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 20 (9): 2338–49. doi:10.1158/1078-0432.CCR-13-3157.